SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation

Sirtuin proteins regulate diverse cellular pathways that influence genomic stability, metabolism and ageing. SIRT7 is a mammalian sirtuin whose biochemical activity, molecular targets and physiological functions have been unclear. Here we show that SIRT7 is an NAD+-dependent H3K18Ac (acetylated lysine 18 of histone H3) deacetylase that stabilizes the transformed state of cancer cells. Genome-wide binding studies reveal that SIRT7 binds to promoters of a specific set of gene targets, where it deacetylates H3K18Ac and promotes transcriptional repression. The spectrum of SIRT7 target genes is defined in part by its interaction with the cancer-associated E26 transformed specific (ETS) transcription factor ELK4, and comprises numerous genes with links to tumour suppression. Notably, selective hypoacetylation of H3K18Ac has been linked to oncogenic transformation, and in patients is associated with aggressive tumour phenotypes and poor prognosis. We find that deacetylation of H3K18Ac by SIRT7 is necessary for maintaining essential features of human cancer cells, including anchorage-independent growth and escape from contact inhibition. Moreover, SIRT7 is necessary for a global hypoacetylation of H3K18Ac associated with cellular transformation by the viral oncoprotein E1A. Finally, SIRT7 depletion markedly reduces the tumorigenicity of human cancer cell xenografts in mice. Together, our work establishes SIRT7 as a highly selective H3K18Ac deacetylase and demonstrates a pivotal role for SIRT7 in chromatin regulation, cellular transformation programs and tumour formation in vivo.

[1]  Henriette O'Geen,et al.  Genome-wide binding of the orphan nuclear receptor TR4 suggests its general role in fundamental biological processes , 2010, BMC Genomics.

[2]  S. Horvath,et al.  Global levels of histone modifications predict prognosis in different cancers. , 2009, The American journal of pathology.

[3]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[4]  D. B. Lombard,et al.  SIRT6 in DNA repair, metabolism and ageing , 2008, Journal of internal medicine.

[5]  Jun S. Liu,et al.  An algorithm for finding protein–DNA binding sites with applications to chromatin-immunoprecipitation microarray experiments , 2002, Nature Biotechnology.

[6]  J. Palvimo,et al.  SUMOylation can regulate the activity of ETS-like transcription factor 4. , 2010, Biochimica et biophysica acta.

[7]  Nancy Hopkins,et al.  Many Ribosomal Protein Genes Are Cancer Genes in Zebrafish , 2004, PLoS biology.

[8]  E. Bober,et al.  Sirt7 Increases Stress Resistance of Cardiomyocytes and Prevents Apoptosis and Inflammatory Cardiomyopathy in Mice , 2008, Circulation research.

[9]  S. Horvath,et al.  Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Sinclair,et al.  Mammalian sirtuins: biological insights and disease relevance. , 2010, Annual review of pathology.

[11]  Panayiotis V. Benos,et al.  STAMP: a web tool for exploring DNA-binding motif similarities , 2007, Nucleic Acids Res..

[12]  Michael M. Murphy,et al.  Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. , 2005, Cell metabolism.

[13]  Michael Grunstein,et al.  Adenovirus Small e1a Alters Global Patterns of Histone Modification , 2008, Science.

[14]  Matteo Pellegrini,et al.  Epigenetic Reprogramming by Adenovirus e1a , 2008, Science.

[15]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[16]  T. Golub,et al.  Identification of RPS14 as a 5q- syndrome gene by RNA interference screen , 2007, Nature.

[17]  Philippe Collas,et al.  Q2ChIP, a Quick and Quantitative Chromatin Immunoprecipitation Assay, Unravels Epigenetic Dynamics of Developmentally Regulated Genes in Human Carcinoma Cells , 2007, Stem cells.

[18]  Izumi Horikawa,et al.  Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. , 2005, Molecular biology of the cell.

[19]  Anjanabha Saha,et al.  ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression , 2006, Nature.

[20]  Howard Y. Chang,et al.  ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation. , 2009, Molecular cell.

[21]  Ian M. Fingerman,et al.  One-pot shotgun quantitative mass spectrometry characterization of histones. , 2009, Journal of proteome research.

[22]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[23]  Seung-Jae V. Lee,et al.  Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans , 2007, Aging cell.

[24]  Michael Q. Zhang,et al.  Combinatorial patterns of histone acetylations and methylations in the human genome , 2008, Nature Genetics.

[25]  G. Viglietto,et al.  Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues , 2002, British Journal of Cancer.

[26]  L. Guarente,et al.  Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. , 2006, Genes & development.

[27]  A. Braithwaite,et al.  Adenovirus-induced alterations of the cell growth cycle: a requirement for expression of E1A but not of E1B , 1983, Journal of virology.

[28]  P. Shiels,et al.  Altered sirtuin expression is associated with node-positive breast cancer , 2006, British Journal of Cancer.

[29]  Z. Weng,et al.  Genomic Binding Profiles of Functionally Distinct RNA Polymerase III Transcription Complexes in Human Cells , 2010, Nature Structural &Molecular Biology.

[30]  K. Waltering,et al.  Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells , 2008, Oncogene.

[31]  C. Hauser,et al.  Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors* , 2004, Journal of Biological Chemistry.

[32]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[33]  M. Mann,et al.  Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. , 2003, Analytical chemistry.

[34]  S. Schreiber,et al.  A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  References , 1971 .

[36]  D. Beach,et al.  Cellular senescence bypass screen identifies new putative tumor suppressor genes , 2008, Oncogene.

[37]  Brian K. Kennedy,et al.  Sirtuins in Aging and Age-Related Disease , 2006, Cell.

[38]  Ole Winther,et al.  JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update , 2007, Nucleic Acids Res..

[39]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[40]  Scott A. Busby,et al.  Chemical derivatization of histones for facilitated analysis by mass spectrometry , 2007, Nature Protocols.

[41]  Bruce Stillman,et al.  Chromatin Association of Human Origin Recognition Complex, Cdc6, and Minichromosome Maintenance Proteins during the Cell Cycle: Assembly of Prereplication Complexes in Late Mitosis , 2000, Molecular and Cellular Biology.

[42]  R. Frye.  ‘SIRT8’ expressed in thyroid cancer is actually SIRT7 , 2002, British Journal of Cancer.

[43]  Howard Y. Chang,et al.  SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin , 2008, Nature.